RxDoctor Payments Data

Joseph Micca, MD

Geriatric Medicine · Marietta, GANPI 1376655712

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $106,675 of the $130,369 with a category attached, or 81.8%. Lilly USA, LLC accounts for 99.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $61,426 and has fallen 99.8% since, to $114 in 2023. Among geriatric medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$130,369in general payments, 2019–2025

Across 312 payments — averaging $417.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$130K
  • Eli Lilly$740
  • Neurocrine Biosciences, Inc.$114

What the payments were for

  • Consulting fees$4,3753%
  • Speaking & faculty fees$106,67582%
  • Travel & lodging$15,40512%
  • Food & beverage$3,9143%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC309$129,514
Eli Lilly2$740
Neurocrine Biosciences, Inc.1$114

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$130,369 in reported general payments places this provider in the 95th percentile of 75 geriatric medicine providers in Georgia.

See all geriatric medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$21,537
Medicare patients
40
Services billed
211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban138$39,396
TrulicityDulaglutide28$17,881
MyrbetriqMirabegron69$15,851
XareltoRivaroxaban30$8,205
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$7,763
AuryxiaFerric Citrate17$5,354
Potassium Chloride140$5,154
Duloxetine Hcl111$4,940
Calcitonin-SalmonCalcitonin,salmon,synthetic49$3,826
RivastigmineRivastigmine Tartrate23$2,830
Pantoprazole Sodium60$1,699
Divalproex Sodium38$1,570
Olanzapine39$1,330
Gabapentin62$1,320
Levothyroxine Sodium123$1,261

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Olanzapine$129,514$19,21167 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 75 geriatric medicine providers in Georgia.

Other geriatric medicine in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →